Showing 4621-4630 of 5646 results for "".
- Timing of Cataract Removal in Infancy May Affect Glaucoma Riskhttps://modernod.com/news/timing-of-cataract-removal-in-infancy-may-affect-glaucoma-risk/2478700/A decade after undergoing cataract removal in infancy a substantial and increasing proportion of patients develop glaucoma or become glaucoma suspects, according to a secondary analysis of a randomized clinical trial, Reuters reported.
- EU Authorizes First COVID-19 Vaccine With Pfizer, BioNTech’s Comirnatyhttps://modernod.com/news/eu-authorizes-first-covid-19-vaccine-with-pfizer-biontechs-comirnaty/2478691/The European Commission on Monday granted a conditional marketing authorization to Pfizer and BioNTech’s coronavirus vaccine BNT162b2, which will go by the name Comirnaty, with the decision coming mere hours after the Committee for Medicinal Products for Human Use (CHMP) gave its backing fo
- Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase 3 Studies for DMEhttps://modernod.com/news/genentechs-faricimab-meets-primary-endpoint-and-shows-strong-durability-across-two-global-phase-3-studies-for-dme/2478687/Genentech announced positive topline results from two identically designed global phase 3 studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that
- CureVac and the University Medical Center Mainz Start Phase 3 Clinical Trial for COVID-19 Vaccine Candidatehttps://modernod.com/news/curevac-and-the-university-medical-center-mainz-start-phase-3-clinical-trial-for-covid-19-vaccine-candidate-cvncov-in-healthcare-workers/2478683/CureVac NV announced that the first participant in a clinical phase 3 study with its COVID-19 vaccine, CVnCoV, in healthcare workers at the University Medical Center Mainz will be vaccinated on December 22, 2020. The study aims to evaluate the safety and immunogenicity of CVnCoV administered as a
- Vaccine Rollout On Track, Expect 300M Doses Through March: Fedshttps://modernod.com/news/vaccine-rollout-on-track-expect-300m-doses-through-march-feds/2478672/If the initial success of the Pfizer-BioNTech rollout continues, and emergency use authorization (EAU) is granted to Moderna and Johnson & Johnson vaccines in development, Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the United Stat
- FDA Review Confirms Efficacy of Moderna’s mRNA-1273 Vaccine Against COVID-19https://modernod.com/news/fda-review-confirms-efficacy-of-modernas-mrna-1273-vaccine-against-covid-19/2478666/According to briefing documents released ahead of an FDA advisory panel meeting on December 17, agency staff concluded that the efficacy of Moderna’s candidate COVID-19 vaccine mRNA-1273 at preventing coronavirus infections 14 days after a second dose was consistent, at 94.1%, with results
- Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopiahttps://modernod.com/news/eyenovia-announces-first-patients-enrolled-in-phase-3-study-of-microline-for-presbyopia/2478667/Eyenovia announced that the first set of patients has been enrolled in the company’s phase 3 VISION-1 study of MicroLine, its proprietary pilocarpine formulation delivered via its Optejet dispenser, for the
- Envision Announces Dates, Calls for Submissions for 2021 Conferenceshttps://modernod.com/news/envision-announces-dates-calls-for-submissions-for-2021-conferences/2478668/Envision announced that it is now accepting submissions for clinical education and research presentations for its two 2021 conferences—events with the goal of closing practice gaps and disseminating the latest advancements in rehabilitation techniques, research and technology surrounding low visi
- Medmont Launches Meridia Advanced Topographerhttps://modernod.com/news/medmont-launches-meridia-advanced-topographer/2478664/Medmont International launched its next generation corneal topographer, the medmont meridia Advanced Topographer, in North America, Australia, and New Zealand. The medmont meridia extends E300’s topography performance by combining it with premium anterior and fluorescein imaging and videos
- Optos Introduces Ultra-Widefield Imaging Advancementshttps://modernod.com/news/optos-introduces-ultra-widefield-imaging-advancements/2478659/Optos has announced the introduction of several advancements to its Ultra-Widefield (UWF) imaging devices. The Optos platform, which includes Daytona, California, Monaco, and Silverstone, is the only retinal imaging t